JHS Svendgaard Laboratories Q2 FY27: net profit down 41% to ₹0.51 crore, revenue down 52%
JHS Svendgaard Laboratories (JHS) said it has published its Q2 FY27 results (consolidated), reporting revenue of ₹21.83 crore (−52.3% year on year), net profit of ₹0.51 crore (−41.0%), earnings per share of ₹0.06. The company is valued at about ₹68.96 crore.
What happened
JHS Svendgaard Laboratories (JHS) told the exchanges on 4 November 2026 at 11:59 AM that it has published its Q2 FY27 results (consolidated), reporting revenue of ₹21.83 crore (−52.3% year on year), net profit of ₹0.51 crore (−41.0%), earnings per share of ₹0.06.
Company snapshot
JHS Svendgaard Laboratories is a micro-cap company, with a market value of about ₹68.96 crore.
The stock last traded at ₹7.89, against a 52-week range of ₹6.26–₹13.69 (42.4% below the high).
Before this filing the shares had moved −33.4% over the month and +8.5% over three months. Average daily turnover over the last 20 sessions was about ₹0.16 crore.
Promoters held 33.85% at the end of Q2 FY27. Foreign institutions owned 2.87% and domestic institutions 0.00%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q2 FY26 | 46 | 0.9 | 0.1 |
| Q3 FY26 | 23 | 0.8 | 0.09 |
| Q4 FY26 | 33 | -3.6 | -0.42 |
| Q1 FY27 | 30 | 1.1 | 0.12 |
| Q2 FY27 | 22 | 0.5 | 0.06 |
What history shows
This is not the company's first results disclosure: BCEIE has 5 earlier filings of this kind on record since May 2026.
After those filings, the stock fell 1.3% on average the next trading day and was down 5.0% on average after five days (4 filings with price data).
Market-wide, 10,609 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 11 Aug 2026 | Board Meeting Outcome for Un-Audited Financial Results For The… | −5.0% | −7.2% |
| 11 Aug 2026 | Financial Results For The Quarter Ended 30Th June, 2026 | −5.0% | −7.2% |
| 26 May 2026 | Audited Financial Results For Quarter And Year Ended 31 March , 2026. | +2.4% | −2.8% |
| 26 May 2026 | Board Meeting Outcome for Outcome For Board Meeting Dated 26 May,… | +2.4% | −2.8% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.